Skip to main content
logo
Vaishali Pharma Limited (NSE:VAISHALI)
India flag India · Delayed Price · Currency is INR
7.35
-0.12 (-1.61%)
Jul 30, 2026, 3:29 PM IST

Vaishali Pharma Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,0881,088990.26862.8696.63758.21
Revenue Growth
9.84%9.84%14.77%23.85%-8.12%41.00%
Gross Profit
136.49136.49133.14118.43149.63123.04
Operating Income
35.1435.14-3.976.388.7464.29
Net Income
41.6541.658.177.1966.0440.24
Earnings Per Share
0.320.320.060.070.590.38
EPS Growth
433.33%433.33%-10.54%-88.65%54.90%284.58%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
14.314.317.1114.575.2911.62
Total Debt
188.9188.9123.18134.92147.36208.11
Net Cash (Debt)
-174.6-174.6-106.08-120.35-142.07-196.49
Net Cash Growth
------
Net Cash Per Share
-1.34-1.34-0.84-1.12-1.27-1.86

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
---180.388.0710.813.19
Capital Expenditures
---3.05-1.11-2.97-8.65
Free Cash Flow
---183.436.967.824.54
Free Cash Flow Growth
----11.08%72.41%-75.93%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
12.55%12.55%13.44%13.73%21.48%16.23%
Operating Margin
3.23%3.23%-0.40%0.73%12.74%8.48%
Pretax Margin
5.07%5.07%1.24%1.07%12.70%7.56%
Profit Margin
3.83%3.83%0.83%0.83%9.48%5.31%
FCF Margin
---18.52%0.81%1.12%0.60%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
22.9715.29186.13206.4323.3017.34
P/FCF Ratio
---213.31196.66153.73
PS Ratio
0.880.591.541.722.210.92